Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Imjudo | tremelimumab-actl | AstraZeneca | N-761289 RX | 2022-10-21 | 2 products |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
hepatocellular carcinoma | — | D006528 | C22.0 |
Expiration | Code | ||
---|---|---|---|
tremelimumab, Imjudo, AstraZeneca AB | |||
2029-10-21 | Orphan excl. |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Melanoma | D008545 | — | — | 111 | 153 | 20 | 2 | 42 | 285 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 24 | 32 | 7 | 1 | 10 | 69 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 13 | 18 | 5 | 1 | 3 | 32 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | 4 | 8 | 2 | 1 | 8 | 21 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 74 | 69 | 4 | — | 5 | 116 |
Non-small-cell lung carcinoma | D002289 | — | — | 39 | 61 | 19 | — | 7 | 107 |
Prostatic neoplasms | D011471 | — | C61 | 18 | 29 | 2 | — | — | 44 |
Colorectal neoplasms | D015179 | — | — | 20 | 27 | 4 | — | 1 | 43 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 11 | 26 | 7 | — | 1 | 38 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 19 | 21 | 1 | — | 2 | 36 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 22 | 20 | 1 | — | — | 36 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 13 | 23 | 6 | — | — | 35 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | 18 | 20 | 2 | — | — | 33 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 12 | 15 | 1 | — | — | 21 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Uveal neoplasms | D014604 | EFO_1001230 | — | 13 | 15 | — | — | — | 24 |
Urologic neoplasms | D014571 | — | C64-C68 | 11 | 8 | — | — | 1 | 15 |
Adenocarcinoma | D000230 | — | — | 2 | 11 | — | — | 1 | 14 |
Myelodysplastic syndromes | D009190 | — | D46 | 10 | 2 | — | — | — | 12 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 9 | 6 | — | — | — | 12 |
Myeloid leukemia acute | D015470 | — | C92.0 | 10 | 1 | — | — | — | 11 |
Multiple myeloma | D009101 | — | C90.0 | 8 | 5 | — | — | — | 11 |
Biliary tract neoplasms | D001661 | — | C24.9 | 2 | 10 | — | — | — | 11 |
Triple negative breast neoplasms | D064726 | — | — | 6 | 6 | — | — | — | 10 |
Fallopian tube neoplasms | D005185 | — | — | 5 | 7 | — | — | — | 10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 4 | — | — | — | — | 4 |
Leukemia myeloid chronic atypical bcr-abl negative | D054438 | — | C92.2 | 3 | — | — | — | — | 3 |
Primary myelofibrosis | D055728 | — | D47.4 | 2 | — | — | — | — | 2 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | 1 | 2 |
Large-cell lymphoma anaplastic | D017728 | — | C84.6 | 2 | — | — | — | — | 2 |
T-cell lymphoma peripheral | D016411 | — | — | 2 | — | — | — | — | 2 |
Ovarian epithelial carcinoma | D000077216 | — | — | 2 | — | — | — | — | 2 |
Anemia | D000740 | HP_0001903 | D64.9 | 1 | — | — | — | — | 1 |
Myeloid leukemia chronic-phase | D015466 | — | — | 1 | — | — | — | — | 1 |
Thrombocytosis | D013922 | HP_0001894 | D75.83 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Autoimmune diseases | D001327 | HP_0002960 | M30-M36 | — | — | — | — | 3 | 3 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | — | — | 2 | 2 |
Myocarditis | D009205 | — | I51.4 | — | — | — | — | 2 | 2 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 2 | 2 |
Microbiota | D064307 | — | — | — | — | — | — | 2 | 2 |
Metagenome | D054892 | — | — | — | — | — | — | 2 | 2 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 1 | 1 |
Cardiomyopathies | D009202 | EFO_0000318 | I42 | — | — | — | — | 1 | 1 |
Pericarditis | D010493 | EFO_0007427 | I30 | — | — | — | — | 1 | 1 |
Vasculitis | D014657 | HP_0002633 | — | — | — | — | — | 1 | 1 |
Drug common name | Tremelimumab |
INN | tremelimumab |
Description | Tremelimumab (human mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | >5GGV:H|heavy chain
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLY
LQMNSLRAEDTAVYYCARDPRGATLYYYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPE
PVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTHHHHHH
>5GGV:L|light chain
DIQMTQSPSSLSASVGDRVTITCRASQSINSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQP
EDFATYYCQQYYSTPFTFGPGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQ
ESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC |
PDB | 5GGU, 5GGV |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108658 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB11771 |
UNII ID | QEN1X95CIX (ChemIDplus, GSRS) |